Correction To: Trends Towards More Active Introduction of Drug Therapy, Emphasizing Methotrexate and Biologic Agents, for Juvenile Idiopathic Arthritis

Clinical Rheumatology - United Kingdom
doi 10.1007/s10067-019-04821-w
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Indirect Treatment Comparison of Abatacept With Methotrexate Versus Other Biologic Agents for Active Rheumatoid Arthritis Despite Methotrexate Therapy in the United Kingdom

Journal of Rheumatology
RheumatologyAllergyImmunology
2012English

Methotrexate in Oligoarticular Persistent Juvenile Idiopathic Arthritis

Pediatric Rheumatology
ImmunologyPediatricsRheumatologyAllergyPerinatologyChild Health
2014English

Pharmacovigilance in Juvenile Idiopathic Arthritis Patients (Pharmachild) Treated With Biologic Agents and/or Methotrexate. Consolidated Baseline Characteristics From Pharmachild and Other National Registries

Pediatric Rheumatology
ImmunologyPediatricsRheumatologyAllergyPerinatologyChild Health
2014English

Prediction of Clinical Non-Response to Methotrexate Treatment in Juvenile Idiopathic Arthritis

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
2012English

Epidemiology and Biologic Treatment Patterns of Systemic Juvenile Idiopathic Arthritis in Ontario

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

Juvenile Idiopathic Arthritis

The Lancet
Medicine
2007English

Juvenile Idiopathic Arthritis

2018English

Juvenile Idiopathic Arthritis

Nederlands Tijdschrift voor Tandheelkunde
Medicine
2018English

Juvenile Idiopathic Arthritis

2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy